Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Wednesday, August 26, 2026

Combined intermittent and continuous theta-burst stimulation of the primary motor cortices for upper-extremity motor recovery and cortical excitability in ischemic stroke:a randomized controlled trial

 Your incompetent? hospital can't even figure out how to deliver music therapy; they will never do anything this complicated! Unless YOU reconstitute the hospital and hire competent staff!

Combined intermittent and continuous theta-burst stimulation of the primary motor cortices for upper-extremity motor recovery and cortical excitability in ischemic stroke:a randomized controlled trial

    We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.

    Abstract

    Background

    Ischemic stroke remains a leading global cause of persistent motor disability, with upper-extremity paresis severely impairing functional independence in most survivors. Intermittent theta-burst stimulation (iTBS) and continuous theta-burst stimulation (cTBS) exert bidirectional neuromodulatory effects on cortical excitability, yet the therapeutic efficacy and neurophysiological mechanisms of combined bilateral TBS targeting primary motor cortices (M1) remain poorly elucidated for subacute stroke rehabilitation.

    Objective

    This randomized, double-blind, sham-controlled pilot trial evaluated the safety, clinical efficacy, and neurophysiological correlates of ipsilesional iTBS combined with contralesional cTBS (i-cTBS) for upper-extremity motor recovery in subacute ischemic stroke, with a hierarchical statistical framework to distinguish confirmatory secondary endpoints from exploratory neurophysiological outcomes.

    Methods

    Sixty-four patients with first-ever unilateral ischemic stroke (within 3 weeks post-onset) and upper-extremity motor impairment were randomized 1:1 to real i-cTBS (n = 32) or sham stimulation (n = 32). All participants received 10 daily sessions (5 sessions per week over 2 consecutive weeks) immediately followed by standardized task-oriented upper-extremity physiotherapy. The primary outcome was total Fugl-Meyer Assessment of Upper Extremity (FMA-UE) score. Tremor, dysmetria, and movement speed subscores served as confirmatory secondary endpoints with Bonferroni correction; motor-evoked potential (MEP) amplitude and resting motor threshold were exploratory neurophysiological measures. Group × time interactions were analyzed using a mixed-design analysis of variance.

    Results

    After the 2-week intervention, a significant group × time interaction was detected for total FMA-UE scores, with greater improvements in the real i-cTBS group (p < 0.001, = 0.365). Tremor and dysmetria subscores showed pronounced benefits, while movement speed showed no between-group difference. MEP amplitude of the ipsilesional M1 was selectively potentiated only in the real group (p < 0.001), and its gains were moderately correlated with motor functional improvement. No serious adverse events related to the intervention were documented.

    Conclusion

    i-cTBS is a safe, well-tolerated intervention that delivers meaningful(Is not 100% recovery, so still a failure per the survivor!) upper-extremity motor recovery in subacute ischemic stroke, with particular amelioration of tremor and dysmetria. The therapeutic effects are likely mediated by bidirectional normalization of interhemispheric excitability gradients and enhanced ipsilesional corticospinal plasticity, supporting its translational potential as an adjuvant therapy for early post-stroke neurorehabilitation.

    No comments:

    Post a Comment